Tissue Repair Ltd

A$0.13As of Sun 8 Nov 2026, 12:00 UTC
ASX:TRPHealthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR (24.18%)
Div yield —
ROE (47.27%)
Biotechnology
Beta (5Y) 0.20
PE TTM —
TSR TTM (62.86%)
Mkt cap A$7.860M
ROIC (30.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.168
29.48%
(24.66%)
Hold 8|5|8|0|8
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
20.87%
41.83%
28.81%
27.26%
Revenue$M
0.638
0.624
0.628
0.647
6.19%
3.01%
0.71%
3.33%
Peers (US$5.399M)
Cap (US$)
PE
6.618M
—
Capital
TTM
5Y
10Y
Leveragex
1.190
0.252
0.195
EBIT/Intx
0.631
0.238
0.241
Own earn%
(139.18)
65.91
67.94
Sh yield%
26.95
36.19
38.81
Owners
Insiders/Inst%
5.67
35.70
Short interest%
4.74
SBC / revenue%
4.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
19–25
$1 testx
−0.1
Incr. ROIC%
10